Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group
Am Heart J
.
2009 Jun;157(6):957-70.
doi: 10.1016/j.ahj.2009.04.010.
Authors
Mihai Gheorghiade
1
,
Kirkwood F Adams
,
John G F Cleland
,
Gad Cotter
,
G Michael Felker
,
Gerasimos S Filippatos
,
Gregg C Fonarow
,
Barry H Greenberg
,
Adrian F Hernandez
,
Sadiya Khan
,
Michel Komajda
,
Marvin A Konstam
,
Peter P Liu
,
Aldo P Maggioni
,
Barry M Massie
,
John J McMurray
,
Mandeep Mehra
,
Marco Metra
,
John O'Connell
,
Christopher M O'Connor
,
Peter S Pang
,
Ileana L Piña
,
Hani N Sabbah
,
John R Teerlink
,
James E Udelson
,
Clyde W Yancy
,
Faiez Zannad
,
Norman Stockbridge
;
Acute Heart Failure Syndromes International Working Group
Affiliation
1
Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. m-gheorghiade@northwestern.edu
PMID:
19464405
DOI:
10.1016/j.ahj.2009.04.010
No abstract available
MeSH terms
Acute Disease
Biomarkers
Clinical Trials, Phase III as Topic*
Electronic Mail
Heart Failure / mortality
Heart Failure / therapy*
Hospitalization
Humans
Surveys and Questionnaires
Treatment Outcome
Substances
Biomarkers